UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                   FORM 10QSB

 -------- ---------------------------------------------------------------------
 [X]      Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
          Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED OCTOBER 31, 2003
 -------- ---------------------------------------------------------------------
          OR
 -------- ---------------------------------------------------------------------
 [ ]      Transition Report Pursuant to Section 13 or 15(d) of the
          Securities Exchange Act of 1934
 -------- ---------------------------------------------------------------------
          For the transition period from to
 -------- ---------------------------------------------------------------------

                         COMMISSION FILE NUMBER: 0-30351

                                 True Health, Inc.
               (Exact name of registrant as specified in its charter)

           ----------------------------------------- -----------------
           Utah                                      75-2263732
           ----------------------------------------- -----------------
           (State of other jurisdiction             (IRS Employer Identification
           of incorporation or organization)         Number)
           ----------------------------------------- --------------------------

                           Kelsy House, 77 High Street
                                 Beckenham, Kent
                                   UK BR3 1AN
                    (Address of principal executive offices)

                             +(44) (0) 208 658 9575
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
                           Yes [ x ]        No [ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of October 31, 2003:      49,017,876

        =============================================================



                         PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

                                TRUE HEALTH, INC.
                           CONSOLIDATED BALANCE SHEET
                                           October 31, 2003
                                   (unaudited)




ASSETS

Current Assets
  Cash                                                              $    51,566
  Accounts receivable, net                                              820,940
  Inventory                                                             106,047
  Income tax refund receivable                                           26,382
  Other                                                                  26,357
                                                                    -----------
         Total Current Assets                                         1,031,292

Equipment, net of accumulated depreciation                              224,381
                                                                    -----------
                                                                    $ 1,255,673
                                                                    ===========



LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities
  Note payable to factor                                             $  373,890
  Current portion of notes payable                                      229,853
  Accounts payable                                                      155,518
  Accrued expenses                                                      210,938
  Advances from stockholder                                             300,235
                                                                    -----------
         Total Current Liabilities                                    1,270,434
Long-term portion of notes payable                                      155,653
                                                                    -----------
         Total Liabilities                                            1,426,087
                                                                    -----------

Commitments


Stockholders' Deficit
  Common stock, $.01 par value; 100,000,000 shares
    authorized; 49,017,876 shares issued and outstanding                490,179
  Additional paid in capital                                            127,500
  Accumulated deficit                                                  (779,385)
  Accumulated other comprehensive loss                                   (8,708)
                                                                    -----------
                Total Stockholders' Deficit                            (170,414)
                                                                    -----------
                                                                    $ 1,255,673
                                                                    ===========





                                TRUE HEALTH, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
       Three Months and Nine Months Ended October 31, 2003 and 2002
                                   (unaudited)


<TABLE>


                                                     Three Months Ended                      Nine Months Ended
                                                   2003              2002             2003             2002
                                                  ----------         ---------        ----------       ---------
<S>                                               <C>                <C>              <C>              <C>
Revenue
- Equipment rentals and sales                      $ 350,423         $ 217,255         $ 948,073       $ 562,452
- Radiographer services
    and placement fees                               935,737            45,168         1,751,299            45,168
- Other                                               16,776             6,213            33,372            29,053
                                                  ----------         ---------        ----------       ---------
                                                   1,302,936           268,636         2,732,744         636,673
                                                  ----------         ---------        ----------       ---------

Cost of sales                                        789,909           57,687         1,570,441            82,973
General and administrative                           514,414          404,838         1,785,937           563,544
Depreciation                                          27,925           25,876            86,098            72,008
                                                  ----------         ---------        ----------       ---------
  Total operating expenses                         1,332,248          488,401         3,442,476           718,525
                                                  ----------         ---------        ----------       ---------
         Net Operating Loss                         ( 29,312)         (219,765)         (709,732)       ( 81,852)

Interest income                                            6                19                 6
Interest expense                                    ( 11,617)         (  1,599)         ( 49,689)         (  3,542)
                                                  ----------         ---------        ----------       ---------
Net loss before taxes                               (140,844)         (221,358)         (759,402)          (85,388)

Income tax recovery                                 ( 13,907)                           ( 17,077)
                                                  ----------         ---------        ----------       ---------
Net Loss                                          $ ( 40,929)        $(207,451)        $(759,402)        $( 68,311)
                                                  ==========         =========        ==========       =========

Basic and diluted loss
  per share                                       $(.00)            $(.01)             $(.02)          $(.00)

Weighted average shares
  outstanding                                     48,342,876        37,500,000        44,106,261        37,500,000


</TABLE>



                                TRUE HEALTH, INC.
                        CONSOLIDATED STATEMENTS OF CASH FLOW
                    Nine Months Ended October 31, 2003 and 2002
                                   (unaudited)


<TABLE>
                                                                                    2003                  2002
                                                                                  ---------             ---------
<S>                                                                               <C>                   <C>
Cash Flows From Operating Activities
  Net loss                                                                         $(759,402)            $( 68,311)


  Adjustments to reconcile net loss to net cash used in operating activities:
    Depreciation                                                                      86,098                 72,008
    Stock and warrants issued for services                                           526,902
    Imputed interest on shareholder notes payable                                     22,848                 3,628
    Changes in:
         Accounts receivable                                                        (605,496)                  835
      Income tax refund receivable                                                                        ( 37,655)
      Inventory                                                                        6,876              ( 15,645             )
         Other current assets                                                       ( 24,188)             (  5,369)
         Accounts payable                                                             25,376                37,672
      Accrued expenses                                                               156,571                64,850
                                                                                  ---------                 ---------
  Net Cash Used In/Generated By Operating Activities                                (564,415)               52,013
                                                                                  ---------                ---------

Cash Flows Used in Investing Activities
  Purchase of equipment                                                            ( 63,503)               (109,370             )
                                                                                  ---------                ---------


Cash Flows From Financing Activities
  Proceeds from stockholders                                                         195,307               104,232
  Common stock issued                                                                 13,500
  Additional paid in capital                                                         127,500
  Net change in note payable to factor                                               438,219
  Payments on notes payable                                                         ( 49,960)             ( 45,111)
                                                                                   ---------             ---------
  Net Cash Provided By Financing Activities                                          724,566                59,121
                                                                                  ---------                ---------
Currency translation adjustment                                                      (45,337)                184
                                                                                   ---------             ---------
Net change in cash                                                                   51,311                 1,948
Cash at beginning of period                                                             255
                                                                                  ---------                  ---------
Cash at end of period                                                            $   51,566               $   1,948
                                                                                  =========                  =========
</TABLE>

                                TRUE HEALTH, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (unaudited)


NOTE 1 - BASIS OF PRESENTATION

The accompanying unaudited interim financial statements of True Health, Inc.
have been prepared in accordance with accounting principles generally accepted
in the United States of America and the rules of the Securities and Exchange
Commission ("SEC"), and should be read in conjunction with the audited financial
statements and notes thereto contained in True Health's significant acquisition
statement filed with the SEC on Form 8-K. In the opinion of management, all
adjustments, consisting of normal recurring adjustments, necessary for a fair
presentation of financial position and the results of operations for the interim
periods presented have been reflected herein. The results of operations for
interim periods are not necessarily indicative of the results to be expected for
the full year. Notes to the financial statements which would substantially
duplicate the disclosure contained in the audited financial statements for the
most recent fiscal year end 2003 as reported in the Form 8-K, have been omitted.


NOTE 2 - STOCK WARRANTS

True Health accounts for non-cash stock-based compensation issued to
non-employees in accordance with the provisions of SFAS No. 123 and EITF No.
96-18, Accounting for Equity Investments That Are Issued to Non-Employees for
Acquiring, or in Conjunction with Selling Goods or Services. Common stock issued
to non-employees and consultants is based upon the value of the services
received or the quoted market price, whichever value is more readily
determinable. During the nine months ended October 31, 2003 and 2002, there were
3,000,000 and zero warrants issued for services, respectively.
<TABLE>
                                                                           Nine months ended
                                                                     2003                  2002
                                                                     ---------             ---------
<S>                                                                  <C>                   <C>
         Net loss as reported                                        $(759,402)            $( 68,311)
         Less: stock based compensation
              determined under fair value-
              based method                                                   0                     0
                                                                     ---------             ---------
              Pro forma net loss                                     $(759,402)            $( 68,311)
                                                                     =========             =========
         Basic and diluted net loss per common share:
              As reported                                                $(.01)                $(.00)
              Pro forma                                                   (.01)                 (.00)
</TABLE>
The weighted average fair value of the stock options granted during 2002 and
2001 was $0.056. Variables used in the Black-Scholes option-pricing model
include (1) 4.0% risk-free interest rate, (2) expected option life is the actual
remaining life of the options as of each year end, (3) expected volatility is
zero, and (4) zero expected dividends.

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

Important Information Regarding Forward-Looking Statements

This Quarterly Report on Form 10-QSB contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Those statements
include indications regarding our intent, belief or current expectations,
including our plans with respect to the sourcing, manufacturing, marketing and
distribution of our products and services, the belief that current levels of
cash and cash equivalents together with cash from operations and existing credit
facilities will be sufficient to meet its working capital requirements for the
next twelve months, our expectations with respect to the performance of the
counterparties to its letter of credit agreements, our plans to invest in
derivative instruments and the collection of accounts receivable, our beliefs
and intent with respect to and the effect of changes in financial accounting
rules on its financial statements. Such statements are subject to a variety of
risks and uncertainties, many of which are beyond the our control, which could
cause actual results to differ materially from those contemplated in such
forward-looking statements, which include, among other things, (i) changes in
the marketplace for our products and services, (ii) the introduction of new
products or pricing changes by our competitors, and (iii) changes in the
economy. Existing and prospective investors are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date
hereof. We undertake no obligation to update or revise the information contained
in this Quarterly Report on Form 10-QSB, whether as a result of new information,
future events or circumstances or otherwise.

Critical accounting policies

We have identified the policies below as critical to our business operations and
the understanding of our results of operations. The impact and any associated
risks related to these policies on our business operations is discussed
throughout Management's Discussion and Analysis of Financial Condition and
Results of Operations where such policies affect our reported and expected
financial results. The preparation of this Quarterly Report on Form 10-QSB
requires us to make estimates and assumptions that affect the reported amount of
assets and liabilities, disclosure of contingent assets and liabilities at the
date of our financial statements, and the reported amounts of revenue and
expenses during the reporting period. There can be no assurance that actual
results will not differ from those estimates.

1) Allowance for doubtful accounts

We evaluate the adequacy of the allowance for doubtful accounts at the end of
each quarter. In performing this evaluation, we analyze the payment history of
significant past due accounts, subsequent cash collections on these accounts and
comparative accounts receivable aging statistics. Based on this information,
along with consideration of the general strength of the economy, we develop what
we consider to be a reasonable estimate of the uncollectible amounts included in
accounts receivable. This estimate involves our significant judgment. Actual
uncollectible amounts may differ from our estimate.



2) Provision for obsolete inventory

We estimate our provision for obsolete inventory based on customer orders sold
below cost, to be shipped in the following period and on the amount of similar
unsold inventory at period end. We analyze recent sales and gross margins on
unsold inventory in further estimating the inventory provision. The impact of
the inventory provision is reflected in cost of sales and the related gross
margins in the period that management deems that inventory has become obsolete.
This estimate involves our significant judgment. Actual gross margins on sales
of excess inventory may differ from our estimate.


Three Months Ended October 31, 2003 Compared to Three Months Ended October 31,
2002

Revenue

Revenue for the three months ended October 31, 2003 increased by $1,034,300, or
385%, when compared to $268,636 in revenue for the three months ended October
31, 2002.

The equipment rentals and sales segment's revenue increased by $133,168, or
61.3%, in the three months ended October 31, 2003, compared to the three months
ended October 31, 2002. This increase reflects the growth in the business over
the past year which mainly arose from an increase in the customer base.

The radiographer services and placement segment commenced operations in
September 2002, from which it has expanded to its current position. The average
monthly revenue for the 3 months ended October 31, 2003 has seen a 504% increase
on the five months to January 31, 2003 and a 219% increase on the three months
to April 30, 2003. Management are extremely pleased with the way this segment
has performed in its first year and will continue to focus its efforts in this
sector to continue its growth in future.

Cost of sales

Cost of sales for the three months ended October 31, 2003, compared to the three
months ended October 31, 2002 are as follows:

<TABLE>
                                            Three months ended     Three months ended
                                              October 31, 2003      October 31, 2002
<S>                                         <C>                    <C>
Equipment rentals and sales                  $ 51,741    14.7%      $16,165     7.5%

Radiographer services and                    $738,168    78.9%      $41,522    91.9%   - placement fees

Total                                        $789,909    60.6%      $57,687    21.5%
</TABLE>

The revenue for the three months to October 31, 2002 was generated entirely from
equipment rentals, with no equipment sales. There are no costs of sale
associated with equipment rentals. Equipment rentals and sales for the 3 months
to October 31, 2003 has still been heavily biased towards equipment rental,
hence the low cost of sales. The cost of sales percentage of revenue associated
with equipment sales is approximately 60%.

General and administrative overheads

General and administrative overheads have increased by $109,756, or 27% for the
three months to October 31, 2003, compared to overheads of $404,838 for the
three months to October 31, 2002.

The main reasons for this increase are as follows:

o        An increase in office space of 100% to accommodate the growing business
         - this includes increased rent, electricity, telephone and other office
         related costs;
o An increase in staff costs due to the recruitment of additional staff to
support the growth in business; o Set-up and ongoing costs for a decontamination
plant to support the growth in the equipment rental business;


The increase in general and administrative overheads for the three months ended
October 31, 2003 is more than compensated for by the increase in revenues less
cost of sales in the three months ended October 31, 2002.

Interest expense

Interest expense of $11,617 for the three months to October 31, 2003, has
increased by $10,018, or 626%, compared with $1,599 for the three months to
October 31, 2002.


Nine Months Ended October 31, 2003 Compared to Nine Months Ended October 31,
2002

Revenue

Revenue for the nine months ended October 31, 2003 increased by $2,096,071, or
329%, when compared to $636,673 in revenue for the nine months ended October 31,
2002.

The equipment rentals and sales segment's revenue increased by $385,621, or
68.5%, in the nine months ended October 31, 2003, compared to the nine months
ended October 31, 2002. The reasons for this increase, and the increase in the
radiographer services and placement fees are as above for the three months.

Cost of sales

Cost of sales for the nine months ended October 31, 2003, compared to the nine
months ended October 31, 2002 are as follows:
<TABLE>
                                        Nine months ended                  Nine months ended
                                        October 31, 2003                   October 31, 2002

                                             Cost of sales                     Cost of sales
                                             % of revenue                         % of revenue
<S>                                    <C>                               <C>
Equipment rentals and sales                 $  236,541    25.0%           $41,451   7.4%

Radiographer services and                   $1,333,900    76.2%           $41,522   91.9%   - placement fees

Total                                        $1,570,441    57.5%             $82,973   13.0%
</TABLE>

The commentary for the nine month period to 31 October 2003 is in line with that
provided for the three months ended October 31, 2003.


General and administrative overheads

General and administrative overheads have increased by $1,222,393, or 217% for
the nine months to October 31, 2003, compared to overheads of $563,544 for the
nine months to October 31, 2002. Reasons for the increase are detailed as
follows:

o        One-off consultancy costs of $499,448 for which payment was given in
         the form of the Company's shares. In accordance with US accounting
         standards, the fair value of these shares has been recorded as an
         expense in the statement of operations. This will be a one-off
         non-recurring charge;
o        One-off costs of the reverse merger with Westmeria Health Care
         Limited, of $37,298;
o        An increase in office space of 100% to accommodate the growing business
         - this includes increased rent, electricity, telephone and other office
         related costs;
o An increase in staff costs due to the recruitment of additional staff to
support the growth in business; and o Set-up and ongoing costs for a
decontamination plant to support the growth in the equipment rental business;

Interest expense

Interest expense has increased by $46,147, or 130% for the nine months to
October 31, 2003, compared to interest of $3,542 for the nine months ended
October 31, 2002, again due to imputed interest as explained for the three
months to October 31, 2003 detailed above.
This increase in interest expense represents imputed interest payable on the
loans provided to us by certain of our employees. These loans have since been
converted to shares hence no interest expense will be imputed in the future.


Liquidity and Capital Resources

We have relied primarily on asset-based borrowings, internally generated funds,
stockholder loans and trade credit to finance our operations. Our capital
requirements primarily result from working capital needed to support increases
in inventory and accounts receivable. Our working capital deficit reduced from
$108,255 as of January 31, 2003 to $239,142 as of October 31, 2003. This
reduction in deficit has been due to the contribution of proceeds from
shareholders. As of October 31, 2003, we had cash and cash equivalents of
$51,566 compared to $255 as of January 31, 2003.

Operating Cash Flow

Net cash used in operating activities for the nine months ended October 31, 2003
was $564,415 compared with net cash generated of $52,013 for the nine months
ended October 31, 2002. This is primarily due to the net loss of $759,402
incurred in the period.

Credit Facilities

We have a loan agreement with bankers, HSBC, for a term loan that advanced
(pound)130,000 in January 2003 and is due for repayment by November 2007. The
loan attracts variable rate interest of 2% over UK base rate and there is a
floating charge over the assets of the Company (5.5% at October 31, 2003).

We also have an accounts receivable factoring arrangement with Venture Finance
which is secured by a floating charge over our assets. This facility has
attracts variable rate interest of 1.75% over UK base rate (5.25% at October 31,
2003).

We believe that current levels of cash and cash equivalents ($51,566 at October
31, 2003) together with cash from operations and funds available under our
credit facilities, will be sufficient to meet our capital requirements for the
next 12 months.

ITEM 3. CONTROLS AND PROCEDURES

At October 31, 2003, we carried out an evaluation, under the supervision and
with the participation of our management, including our Chief Executive Officer
and Chief Financial Officer, of the effectiveness of the design and operation of
our disclosure controls and procedures pursuant to Rule 13a-14 under the
Securities Exchange Act of 1934, as amended. Based upon that evaluation, the
Chief Executive Officer and Chief Financial Officer concluded that our
disclosure controls and procedures are effective in timely alerting them to
material information relating to us required to be included in our periodic SEC
filings.

There have been no significant changes in our internal controls or in other
factors that could significantly affect our controls subsequent to the date of
that evaluation, and no corrective actions with regard to significant
deficiencies and material weaknesses.



                           PART II - OTHER INFORMATION



ITEM 6.    EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits Item Description
     31.1    Certification Pursuant to Section 302 of the Sarbanes-Oxley Act
             of 2002
     31.2    Certification Pursuant to Section 302 of the
             Sarbanes-Oxley Act of 2002
     32      Certification Pursuant to 18 U.S.C. Section 1350, as
             Adopted Pursuant to Section 906 of the Sarbanes-Oxley
             Act of 2002

(b) Report on Form 8-K

On August 25, 2003, we filed a report on Form 8-K related to our change of
fiscal year end date to 31 January.

On September 19, 2003, we filed a report on Form 10QSB relating to our results
for the three and nine months ended 31 July 2003.

On September 24, 2003, we filed a report on Form 8-K/A which related to the
financial results for the year ended 31 January 2003 and the three months ended
30 April 2003 of Westmeria Health Care Limited, a wholly owned subsidiary of
True Health Inc.

On September 25, 2003, we filed an amended report on Form 8-K/A which related to
the financial results for the year ended 31 January 2003 and the three months
ended 30 April 2003 of Westmeria Health Care Limited, a wholly owned subsidiary
of True Health Inc.

On October 27, 2003, we filed a report on Form 8-K which related to outstanding
correspondence with our previous auditor.

On November 21, 2003, we filed a report on Form 8-K/A which related to
outstanding correspondence with our previous auditor.

                                                     SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

         Dated:  December 15, 2003.

                                               TRUE HEALTH, INC.

                                               BY: David Francis
                                                  -------------------
                                                  David Francis, CEO



                                               BY: Ian Wylie
                                                   ------------------
                                                   Ian Wylie, CFO




                                  Exhibit 31.1

                            Certification Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

I, David Francis, certify that:

1.       I have reviewed the quarterly report on Form 10-QSB of True Health,
         Inc. for the period ended October 31, 2003 (this
         "Report");

2.       Based on my knowledge, this Report does not contain any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances under which
         such statements were made, not misleading with respect to the period
         covered by this Report;

3.       Based on my knowledge, the financial statements, and other financial
         information included in this Report, fairly present in all material
         respects the financial condition, results of operations and cash flows
         of the registrant as of, and for, the periods presented in this Report;

4.       The registrant's other certifying officers and I are responsible for
         establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
         we have:

     (a)   designed such disclosure controls and procedures to ensure that
           material information relating to the registrant, including its
           consolidated subsidiaries, is made known to us by others within those
           entities, particularly during the period in which this Report is
           being prepared;
(b)      evaluated the  effectiveness of the registrant's  disclosure  controls
         and procedures as of a date within 90 days prior to the
            filing date of this Report (the "Evaluation Date"); and
(c)         presented in this Report our conclusions about the effectiveness of
            the disclosure controls and procedures based on our evaluation as of
            the Evaluation Date;


     5. The registrant's other certifying officers and I have disclosed, based
     on our most recent evaluation, to the registrant's auditors and the audit
     committee of registrant's board of directors:
(a)           all significant deficiencies in the design or operation of
              internal controls which could adversely affect the registrant's
              ability to record, process, summarize and report financial data
              and have identified for the registrant's auditors any material
              weaknesses in internal controls; and
(b)           any fraud, whether or not material, that involves management or
              other employees who have a significant role in the registrant's
              internal controls; and

     6. The registrant's other certifying officers and I have indicated in this
     Report whether or not there were significant changes in internal controls
     or in other factors that could significantly affect internal controls
     subsequent to the date of our most recent evaluation, including any
     corrective actions with regard to significant deficiencies and material
     weaknesses.

Dated: December 15, 2003


David Francis
--------------------------------------
David Francis, CEO


                                  Exhibit 31.2

                            Certification Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

I, Ian Wylie, certify that:

7.     I have reviewed the quarterly report on Form 10-QSB of True Health, Inc.
       for the period ended October 31, 2003 (this "Report");

8.     Based on my knowledge, this Report does not contain any untrue statement
       of a material fact or omit to state a material fact necessary to make the
       statements made, in light of the circumstances under which such
       statements were made, not misleading with respect to the period covered
       by this Report;

9.     Based on my knowledge, the financial statements, and other financial
       information included in this Report, fairly present in all material
       respects the financial condition, results of operations and cash flows of
       the registrant as of, and for, the periods presented in this Report;

10.    The registrant's other certifying officers and I are responsible for
       establishing and maintaining disclosure controls and procedures (as
       defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
       we have:

       (d)    designed such disclosure controls and procedures to ensure that
              material information relating to the registrant, including its
              consolidated subsidiaries, is made known to us by others within
              those entities, particularly during the period in which this
              Report is being prepared;
       (e)    evaluated the effectiveness of the registrant's disclosure
              controls and procedures as of a date within 90 days prior to the
              filing date of this Report (the "Evaluation Date"); and
       (f)    presented in this Report our conclusions about the effectiveness
              of the disclosure controls and procedures based on our evaluation
              as of the Evaluation Date;

11.    The registrant's other certifying officers and I have disclosed, based on
       our most recent evaluation, to the registrant's auditors and the audit
       committee of registrant's board of directors: (c) all significant
       deficiencies in the design or operation of internal controls which could
       adversely affect the registrant's
              ability to record, process, summarize and report financial data
              and have identified for the registrant's auditors any material
              weaknesses in internal controls; and
       (d)    any fraud, whether or not material, that involves management or
              other employees who have a significant role in the registrant's
              internal controls; and

12.    The registrant's other certifying officers and I have indicated in this
       Report whether or not there were significant changes in internal controls
       or in other factors that could significantly affect internal controls
       subsequent to the date of our most recent evaluation, including any
       corrective actions with regard to significant deficiencies and material
       weaknesses.


Dated: December 15, 2003


Ian Wylie
--------------------------------------
Ian Wylie, CFO






                                   Exhibit 32

         Certification Pursuant to 18U.S.C Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

Each   of the undersigned hereby certifies, for the purposes of section 1350 of
       chapter 63 of title 18 of the United States Code, in his capacity as an
       officer of True Health, Inc. ("True Health"), that, to his knowledge, the
       quarterly report on Form 10-QSB of True Health, Inc. for the period ended
       October 31, 2003, fully complies with the requirements of Section 13(a)
       of the Securities Exchange Act of 1934 and that the information contained
       in such amendment to said report fairly presents, in all material
       respects, the financial condition and results of operation of True
       Health.

Dated: December 15, 2003

David Francis
--------------------------------------
David Francis, CEO




Ian Wylie
--------------------------------------
Ian Wylie, CFO